Jewels Doskicz
What’s Keeping Glucagon Out of Reach for Many with T1D?
You may assume that for someone living with type 1 diabetes (T1D), keeping life-saving glucagon on hand would be a…
Thinking About Type 1 Diabetes Autoantibody Screening? Here’s What to Consider
If you or a loved one lives with type 1 diabetes (T1D), you may worry about T1D risk in other…
The Language of Type 1 Diabetes: Why Words Matter
Language doesn’t just tell a story — it shapes how we think, what we believe, and how we feel about ourselves and the world around us. This is especially true in healthcare, where word choices can reinforce stigma and misconceptions or foster empathy, understanding, and empowerment. For those living with type 1 diabetes (T1D),…
Understanding Time in Range, GMI, and A1C in Type 1 Diabetes
Move over A1C? Well, not so fast. While we rely more and more on data points from wearable continuous glucose monitors (CGMs)…
Out of Insulin? Expert Tips from Diana Isaacs, PharmD
Picture this: You’re on vacation with your last vial of insulin in hand when — oops — you accidentally drop it, a hotel…
Protein, Glucose, and T1D: Expert Insights from Jennifer Okemah, MS, RDN
Have you ever wondered how dietary protein affects type 1 diabetes (T1D)? With the new Dietary Guidelines for Americans, emphasizing protein, it’s an…
Type 2 Diabetes in Youth: A Rising Concern
Key Takeaways Type 2 diagnosis rates are increasing among young people, especially in certain minority groups who are disproportionately affected. …
Diabetes Technology Insights: An Interview with Medtronic’s Chief Medical Officer
Thyroid Eye Disease (TED): What You Need to Know
Immunosuppressants in T1D Research: Expert Opinions from Diabetes Pharmacist Diana Isaacs
Current research on type 1 diabetes (T1D) and islet cells often uses immunosuppressant drugs to prevent rejection of implanted cells. While some studies…
